Application of balloon-occluded retrograde transvenous obliteration in treatment of liver cirrhosis complications
- VernacularTitle:球囊阻断逆行静脉血管栓塞术在肝硬化并发症治疗中的应用
- Author:
Lixia XIN
1
;
Hongbin ZHU
2
;
Xiao LIU
1
;
Chunqing ZHANG
2
Author Information
- Publication Type:Review
- Keywords: Balloon Occlusion; Liver Cirrhosis; Esophageal and Gastric Varices; Hepatic Encephalopathy
- From: Journal of Clinical Hepatology 2026;42(2):452-456
- CountryChina
- Language:Chinese
- Abstract: Gastric variceal rupture and bleeding and hepatic encephalopathy are common and life-threatening complications in decompensated cirrhosis. As a minimally invasive interventional technique， balloon-occluded retrograde transvenous obliteration （BRTO） has made significant progress in the clinical management of gastric varices and hepatic encephalopathy in recent years. This article systematically reviews the technical principles， indications （e.g.， isolated gastric varices and refractory hepatic encephalopathy）， clinical efficacy （an acute hemostasis rate of 85% — 95%， a 1-year rebleeding rate of <15%， and an improvement rate of 60% — 80% for hepatic encephalopathy）， and safety （including complications such as renal impairment and elevated portal vein pressure） of BRTO. Meanwhile， this article discusses the advantages and disadvantages of BRTO and conventional treatment modalities （e.g.， transjugular intrahepatic portosystemic shunt and endoscopic treatment） and reviews the latest technological improvements in recent years， such as coil-assisted retrograde transvenous obliteration and plug-assisted retrograde transvenous obliteration. Future research should focus on the precision of patient selection （e.g.， stratification based on hemodynamic parameters）， the optimization of embolic materials （e.g.， application of new biodegradable embolic agents）， and the development of individualized treatment regimens， so as to improve efficacy and reduce the risk of complications.
